Proteostasis Therapeutics, Inc. was a big mover last session, as the company saw its shares rise nearly 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company — as the stock is now up 127.6% in the past one-month time frame.

The move came after the company reported narrower-than-expected loss in fourth-quarter 2017.

The company has not seen any estimate revisions over the past one month, while the Zacks Consensus Estimate for the current quarter also remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Proteostasis Therapeutics currently has a Zacks Rank #3 (Hold), while its Earnings ESP is positive.

A better-ranked stock in the Medical - Biomedical and Genetics industry is Pieris Pharmaceuticals, Inc. (PIRS Quick QuotePIRS - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is PTI going up? Or down? Predict to see what others think: Up or Down

The Hottest Tech Mega-Trend of All
 
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>